Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

The GHRP peptide group: from strongest to weakest according to research

The GHRP peptide group: from strongest to weakest according to research GHRP-6 is known for being a big appetite stimulator, but it is not the strongest GH releasing peptide in the GHRP family. There are other members of the GHRP family we should briefly look

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

The GHRP peptide group: from strongest to weakest according to research

GHRP-6 is known for being a big appetite stimulator, but it is not the strongest GH releasing peptide in the GHRP family. There are other members of the GHRP family we should briefly look at.

This list is in order from strongest to weakest.

1. Hexarelin – The strongest in the family known to give the biggest pulse of all. Will create prolactin and cortisol side effects. Desensitization will happen regardless of the dose.

2. GHRP-2 – Second in the category, however, desensitization is unclear if used beyond saturation dose.

3. GHRP-6 – Third in the lineup for potency, and when shots are broken up, desensitization does not occur. Slightly creates prolactin and cortisol issues.

4. Ipamorelin – This mildest in the bunch, does not create prolactin or cortisol and at very large doses was shown to give a large release of GH without desensitization.

Warning

THE GOODS OFFERED BY THE SELLER IS INTENDED FOR SCIENTIFIC AND DEVELOPMENT PURPOSES ONLY. The goods offered by the Seller include chemical substances that shall not be used as a drug, medicine, active substance, medical aid, cosmetic product, a substance for production of a cosmetic product neither for human consumption that is any food or food supplement or otherwise similarly used on humans or animals.

References / Links

Bowers, C. Y., Momany, F., Reynolds, G. A., Chang, D., Hong, A., & Chang, K. (1984). On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology, 114(5), 1537–1545. PubMed

Ghigo, E., Arvat, E., Gianotti, L., Imbimbo, B. P., Lenaerts, V., Deghenghi, R., & Camanni, F. (1994). Growth hormone-releasing activity of Hexarelin, a new synthetic hexapeptide, in man. Journal of Clinical Endocrinology & Metabolism, 78(4), 693–698. PubMed

Bowers, C. Y. (1998). Growth hormone-releasing peptide (GHRP). Cellular and Molecular Life Sciences, 54(12), 1316–1329. PubMed

Ghigo, E., Arvat, E., Gianotti, L., Broglio, F., & Camanni, F. (1997). Growth hormone-releasing peptides. European Journal of Endocrinology, 136(5), 445–460. PubMed

Jönsson, J. O., Eden, S., Kvist, O., Isaksson, O. G., & Bengtsson, B. A. (1998). Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology, 139(5), 552–561. PubMed

P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →